Best Grants for Community Centers in Virgin Islands

The NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22) supports early-career independent researchers to transition from postdoctoral positions to assistant professor roles. This award aims to enhance diversity in the biomedical workforce, offering funding opportunities for innovative research projects. Key application deadlines span from February 2025 to October 2027. The program is funded by the US Department of Health & Human Services, specifically the National Institutes of Health (NIH).

The NIH Career Transition Award (K22) supports exceptional basic and clinical investigators in developing independent research skills through a two-phase program: an intramural appointment at NIH followed by support at an extramural institution. This award specifically aids NINDS intramural neurologist and neurosurgeon scientists in transitioning to independent academic faculty roles, fostering the engagement of clinician-scientists in both funded scientific research and clinical practices.

This funding opportunity aims to support innovative research projects targeting previously undruggable classes of proteins associated with challenging human diseases. By encouraging early-stage exploratory projects, it seeks to foster the development of novel methods and agents that can selectively modulate these hard-to-target proteins, ultimately advancing therapeutic strategies and improving patient outcomes.

The BRAIN Initiative seeks innovative proposals for preclinical proof of concept studies on novel recording and modulation technologies aimed at diagnosing and treating central nervous system (CNS) disorders. This initiative supports diverse, multidisciplinary teams to enhance our understanding of the human CNS and prepare technologies for first-in-human studies. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 60 days prior to the proposal deadline.

The Advanced Rehabilitation Research Training (ARRT) Program, funded by the US HHS: Administration for Community Living, aims to enhance the skills of researchers in the field of disability and rehabilitation. By providing advanced training over a three-year period, this program focuses on improving community living and participation outcomes for individuals with disabilities. It seeks to equip scholars with the necessary tools to conduct high-quality, multidisciplinary research, ultimately benefiting the disability community.

The NIH Common Fund is launching the RNomics program to advance RNA research through innovative technologies. This initiative focuses on developing tools for comprehensive analysis of RNA molecules, addressing current methodological limitations. Key priorities include sequencing RNA, detecting modifications, and studying RNA function across various biological contexts. The program encourages high-risk, early-stage projects that demonstrate potential for significant impact. Successful Phase 1 projects may transition to Phase 2, aimed at delivering validated resources for the research community.

The BRAIN Initiative invites applications for clinical studies aimed at advancing devices for recording and modulation in the human central nervous system. This funding opportunity focuses on small clinical trials that provide vital data for device development, particularly for treatments of central nervous system disorders. Investigators are encouraged to explore both non-significant and significant risk studies to enhance understanding of device functionality and design, ultimately contributing to improved clinical outcomes.

The RNomics Molecular Standards initiative, supported by the NIH Common Fund, aims to enhance research on RNA molecules by developing standardized references. This program will facilitate the creation, testing, and distribution of RNA molecular reference standards, which are crucial for ensuring consistency and reliability in RNA research. By providing guidance on best practices and planning for long-term availability, RNomics will help advance technologies that analyze RNA sequences and functions, ultimately improving health and disease understanding.

The RNomics Outreach and Coordination (ROC) Center, established by the NIH Common Fund, aims to enhance understanding of RNA molecules through integrated analysis. This center will serve as a hub for data management and community engagement, developing a central data portal, supporting data standards, and coordinating consortium-wide analyses. By fostering collaborations and providing training, the ROC Center seeks to ensure the long-term availability of essential RNomics resources, ultimately advancing health and disease research.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Health Equity Fund

Help with healthcare costs for hemophilia (health equity fund)

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The National Institute of Dental and Craniofacial Research (NIDCR) is inviting innovative research applications on the causal relationships between human behaviors and oral-systemic health impacts, particularly for people with chronic conditions. This funding opportunity encourages the exploration of biological, environmental, and psychosocial factors contributing to health outcomes. Projects should aim for translation into clinical trials to manage dental and craniofacial conditions effectively. Collaboration among diverse health experts is strongly encouraged.

The NIH Career Transition Award (K22) aims to support outstanding clinician-scientists in developing independent research skills. This grant facilitates a two-phase program, starting with an intramural appointment at the NIH followed by support at an extramural institution. Designed for NINDS intramural neurologist- and neurosurgeon-scientists, it helps them transition to independent academic faculty roles, enabling them to engage in funded scientific research alongside clinical activities.

The Leadership Development Grants for Young Women, offered by Presbyterian Women, empower women aged 18-30 to enhance their leadership skills through participation in educational events. With grants of up to $2,000 for the Commission on the Status of Women and $1,000 for the Ecumenical Advocacy Days, this program fosters personal and community growth within the Presbyterian Church (U.S.A.). Eligible applicants must be active in PC(USA) and meet specific grant requirements.

The Summer Research Education Experience Program (R25) is designed to enhance educational activities in biomedical and clinical research. This program aims to provide high school and undergraduate students, as well as science teachers, with immersive research experiences during summer breaks. Applications for standard and renewal submissions are due on March 18, 2025, and consecutive years thereafter, while AIDS-related applications are due on May 7 in the same years. Letters of Intent are encouraged.

The Established Clinician Investigator Award to Support Mentoring (KS1) is designed to provide established clinician investigators with dedicated time for mentoring early-career clinician research scientists. This initiative by the US Dept. of Health & Human Services: National Institutes of Health (NIH) aims to enhance the quality of mentorship, fostering the development of future leaders in clinical research. It supports a sustained commitment to training and guidance, ensuring a robust pipeline of skilled professionals.

The Mentored Career Transition Award (KT1/R00) offers a biphasic funding opportunity for up to 5 years, supporting the transition of postdoctoral researchers to independent faculty positions. The first phase provides 1-2 years of mentored career development, while the second phase grants up to 3 years of independent research support, contingent upon satisfactory progress and faculty appointment. This grant aims to enhance the capacity of early-career researchers in achieving research-intensive roles.

This funding opportunity aims to support innovative mechanistic research that enhances precision probiotic therapies. It encourages studies that identify person-specific features influencing probiotic responses, focusing on the variability among individuals. The goal is to develop strategies to improve probiotic clinical outcomes by understanding the biological patterns linked to probiotic effectiveness. Applications should demonstrate rigorous mechanistic studies and preliminary data supporting the correlation between host biology and probiotic response.

The NIOSH K01 grant offers vital support for early-career researchers in occupational health, providing 'protected time' for mentorship and professional development. This funding aims to bridge the gap from postdoctoral training to independent research, fostering the next generation of investigators. By emphasizing skill enhancement and independence, the program plays a crucial role in advancing safety and health research. Applicants must articulate their mentorship needs and demonstrate the potential for increased autonomy in their research careers.

The RNomics Technology Enhancement Centers, supported by the NIH Common Fund, aim to enhance tools for comprehensive RNA analysis, facilitating insights into health and disease. This initiative focuses on developing technologies for RNA sequencing, modification mapping, and functional testing. By fostering collaborations and strengthening existing resources, RTECs will advance the study of RNA molecules, ensuring broad community access to improved experimental and computational methods.

The NCI CURE Mentored Clinical Scientist Research Career Development Award (K08) aims to support individuals with clinical doctoral degrees in developing research careers that address national health-related needs. This program focuses on enhancing the research capabilities of underrepresented clinical scientists in cancer research, including health disparities. Awardees receive protected time for supervised research training, preparing them to compete for future research project grants. Key deadlines for applications span from February 2025 to October 2027.

The Interventions to Reduce Sleep Health Disparities (R01) grant aims to fund non-pharmacological strategies that enhance sleep health and address disparities in sleep among affected populations. The program emphasizes innovative approaches to examine sleep as a crucial element in mitigating health disparities across various health outcomes. Deadlines for applications range from February 2025 to June 2027, supporting both standard and renewal submissions under the National Institutes of Health.

The AHRQ Small Research Projects (R03) program supports short-term research endeavors in primary care, enabling innovative pilot studies, secondary data analysis, and the development of research methodologies. This initiative encourages researchers to explore new technologies and approaches within limited resource frameworks, fostering advancements in healthcare quality and efficiency. Applications are due by 5:00 PM local time of the applicant organization, emphasizing the importance of timely submission.

The NIH HEAL Initiative PainCare Clinician Training Program (PCTP) aims to develop a new generation of independent investigators in patient-oriented research focused on pain management. This K23 award provides essential funding to support early-career researchers, enabling them to establish independent research programs aligned with the NIH HEAL Initiative. Key application deadlines span from October 2024 to June 2027, ensuring opportunities for renewals and resubmissions. This program is vital for advancing pain management research.

The Innovative Programs to Enhance Research Training (IPERT) initiative by the NIH aims to support innovative educational activities that enhance the skills of participants across various career stages in the biomedical research field. This program focuses on courses for skills development, mentoring activities, and curriculum or methods development, ensuring a robust structure for leadership, recruitment, and evaluation.

The NSF MPS Chemistry Research Programs support groundbreaking research in chemical sciences, encompassing areas such as chemical catalysis, measurement, imaging, and theory. This initiative encourages innovative proposals that can lead to transformative advancements, without the necessity of immediate commercial applications. Researchers interested in exploring foundational concepts that could shape the future of chemistry are invited to submit their ideas for funding.

The Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award (F99/K00) supports late-stage graduate students from diverse backgrounds in transitioning to postdoctoral positions. This phased award aims to facilitate doctoral dissertation completion and subsequent career development in biomedical research. Participants will engage in mentoring, networking, and professional development activities, preparing them for impactful careers that often require postdoctoral training. Key deadlines for applications span from February 2025 to January 2028.